Evidence map›Paper›PMID 30559962›Full record

ArticlePerioperative medicine (London, England)2018

What is the effect of perioperative intravenous iron therapy in patients undergoing non-elective surgery? A systematic review with meta-analysis and trial sequential analysis.

Akshay Shah, Antony J R Palmer, Sheila A Fisher, Shah M Rahman, Susan Brunskill, Carolyn Doree, Jack Reid, Anita Sugavanam, Simon J Stanworth

Open access · goldAbstract read
In one paragraph

Article in Perioperative medicine (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Akshay Shah1Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Level 4 Academic Block, Oxford, OX3 9DU UK.ORCID 0000-0002-1869-2231
Antony J R Palmer2Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.
Sheila A Fisher4Systematic Review Initiative, NHS Blood & Transplant, Oxford, UK.
Shah M Rahman3Frimley Health NHS Foundation Trust, Camberley, Surrey GU16 7UJ UK.
Susan Brunskill4Systematic Review Initiative, NHS Blood & Transplant, Oxford, UK.
Carolyn Doree4Systematic Review Initiative, NHS Blood & Transplant, Oxford, UK.
Jack Reid5Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Anita Sugavanam5Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Simon J Stanworth1Radcliffe Department of Medicine, John Radcliffe Hospital, University of Oxford, Level 4 Academic Block, Oxford, OX3 9DU UK.
NHS Blood and Transplant · GBUniversity Hospitals Sussex NHS Foundation Trust · GBFrimley Health NHS Foundation Trust · GBJohn Radcliffe Hospital · GBNuffield Orthopaedic Centre · GB

Funding

Department of Health DRF-2017-10-094
6 · The paper itself

Abstract

backgroundGuidelines to treat anaemia with intravenous (IV) iron have focused on elective surgical patients with little attention paid to those undergoing non-elective/emergency surgery. Whilst these patients may experience poor outcomes because of their presenting illness, observational data suggests that untreated anaemia may also be a contributing factor to poor outcomes. We conducted a systematic review to investigate the safety and efficacy of IV iron in patients undergoing non-elective surgery.

methodsWe followed a pre-defined review protocol and included randomised controlled trials (RCTs) in patients undergoing non-elective surgery who received IV iron. Primary outcomes were all-cause infection and mean difference in haemoglobin (Hb) at follow-up. Secondary outcomes included transfusion requirements, hospital length of stay (LOS), health-related quality of life (HRQoL), mortality and adverse events.

resultsThree RCTs (605 participants) were included in this systematic review of which two, in both hip fracture (HF) patients, provided data for meta-analysis. Both of these RCTs were at low risk of bias. We found no evidence of a difference in the risk of infection (RR 0.99, 95% CI 0.55 to 1.80,

conclusionWe found no conclusive evidence of an effect of IV iron on clinically important outcomes in patients undergoing non-elective surgery. Further adequately powered trials to evaluate its benefit in emergency surgical specialties with a high burden of anaemia are warranted.

trial registrationThis systematic review was registered on PROSPERO (CRD42018096288).

Indexed as

AnaemiaIronSurgery

Identifiers

PMID30559962
PMCPMC6290500
OpenAlexW2903600857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.